| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
20,853 |
17,524 |
$2.25M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,232 |
27,269 |
$1.94M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,721 |
11,127 |
$1.76M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,422 |
8,046 |
$1.49M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,509 |
9,038 |
$768K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,961 |
3,820 |
$686K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,530 |
7,147 |
$530K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,026 |
1,974 |
$432K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,423 |
5,534 |
$408K |
| 36415 |
Collection of venous blood by venipuncture |
11,944 |
9,731 |
$346K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,495 |
3,076 |
$295K |
| 80053 |
Comprehensive metabolic panel |
17,199 |
14,349 |
$281K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,659 |
1,696 |
$274K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,381 |
1,341 |
$274K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
776 |
718 |
$195K |
| 87631 |
|
1,701 |
1,674 |
$193K |
| 70450 |
Computed tomography, head or brain; without contrast material |
813 |
782 |
$192K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
880 |
872 |
$182K |
| 81025 |
|
3,396 |
3,311 |
$171K |
| 59025 |
Fetal non-stress test |
1,168 |
593 |
$169K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,191 |
941 |
$163K |
| G0378 |
Hospital observation service, per hour |
419 |
364 |
$151K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,747 |
1,746 |
$133K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,420 |
1,418 |
$112K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,704 |
1,499 |
$101K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,347 |
1,323 |
$95K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,600 |
2,071 |
$84K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,089 |
2,067 |
$76K |
| 97161 |
|
919 |
908 |
$75K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,520 |
2,508 |
$73K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
765 |
764 |
$73K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,356 |
3,267 |
$72K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,031 |
2,752 |
$59K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
291 |
285 |
$57K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
529 |
529 |
$52K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,619 |
6,465 |
$50K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
317 |
313 |
$49K |
| 99173 |
|
969 |
945 |
$48K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,158 |
2,136 |
$47K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,424 |
1,410 |
$47K |
| 85610 |
|
3,234 |
2,557 |
$46K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,403 |
1,402 |
$39K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
420 |
420 |
$38K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,429 |
1,166 |
$38K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,294 |
4,263 |
$37K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,651 |
1,635 |
$37K |
| 76801 |
|
473 |
425 |
$36K |
| 80061 |
Lipid panel |
5,414 |
5,376 |
$36K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
4,528 |
3,939 |
$36K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
188 |
186 |
$35K |
| 90715 |
|
1,016 |
1,014 |
$33K |
| 90686 |
|
1,243 |
1,236 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
3,823 |
3,646 |
$31K |
| 86850 |
|
835 |
797 |
$31K |
| 85027 |
|
6,822 |
6,119 |
$28K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,086 |
2,024 |
$24K |
| 99215 |
Prolong outpt/office vis |
234 |
224 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,356 |
11,453 |
$23K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
102 |
99 |
$23K |
| 83655 |
|
1,127 |
1,106 |
$20K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,007 |
1,733 |
$20K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,241 |
1,241 |
$19K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
13 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,347 |
1,319 |
$18K |
| 82607 |
|
1,501 |
1,470 |
$18K |
| 84439 |
|
2,493 |
2,451 |
$18K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
243 |
243 |
$16K |
| 82728 |
|
1,345 |
1,282 |
$15K |
| 90648 |
|
775 |
774 |
$14K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,842 |
1,806 |
$14K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
202 |
133 |
$14K |
| 90670 |
|
797 |
796 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
187 |
187 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,196 |
2,947 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
374 |
363 |
$12K |
| 90677 |
|
275 |
275 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,912 |
3,628 |
$11K |
| 76770 |
|
129 |
129 |
$11K |
| 87632 |
|
168 |
166 |
$11K |
| 76830 |
Ultrasound, transvaginal |
137 |
137 |
$11K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
73 |
55 |
$10K |
| 0012A |
|
282 |
282 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,199 |
2,864 |
$10K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
102 |
102 |
$10K |
| 90661 |
|
251 |
251 |
$9K |
| 86901 |
|
980 |
940 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,758 |
4,688 |
$9K |
| 86900 |
|
977 |
937 |
$9K |
| 83540 |
|
1,333 |
1,267 |
$8K |
| 82746 |
|
774 |
745 |
$8K |
| 81001 |
|
4,486 |
4,080 |
$8K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
315 |
311 |
$8K |
| 90680 |
|
502 |
502 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
488 |
486 |
$7K |
| 90723 |
|
472 |
472 |
$7K |
| 81002 |
|
2,520 |
1,999 |
$7K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
116 |
110 |
$6K |
| 0011A |
|
285 |
285 |
$6K |
| 86803 |
|
730 |
724 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
968 |
852 |
$6K |
| 92551 |
|
1,267 |
1,263 |
$6K |
| 85380 |
|
581 |
569 |
$6K |
| 99385 |
|
49 |
49 |
$6K |
| 87081 |
|
3,153 |
3,093 |
$5K |
| 83735 |
|
2,664 |
2,257 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,236 |
1,213 |
$5K |
| 84702 |
|
724 |
545 |
$5K |
| 90633 |
|
318 |
318 |
$5K |
| 99441 |
|
268 |
263 |
$5K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
53 |
53 |
$5K |
| 73630 |
|
341 |
337 |
$5K |
| 73030 |
|
414 |
409 |
$5K |
| 81003 |
|
2,845 |
2,704 |
$5K |
| 73562 |
|
215 |
213 |
$4K |
| 73610 |
|
431 |
421 |
$4K |
| 83880 |
|
180 |
158 |
$4K |
| 84466 |
|
436 |
417 |
$4K |
| 87480 |
|
735 |
728 |
$4K |
| 87150 |
|
122 |
121 |
$4K |
| 87660 |
|
757 |
750 |
$4K |
| 99442 |
|
113 |
109 |
$4K |
| 82570 |
|
1,062 |
1,018 |
$4K |
| 87510 |
|
735 |
728 |
$4K |
| 90707 |
|
216 |
216 |
$4K |
| 99406 |
|
312 |
303 |
$4K |
| 86780 |
|
348 |
347 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
1,321 |
1,272 |
$4K |
| 87340 |
|
403 |
401 |
$4K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
158 |
77 |
$4K |
| 73110 |
|
253 |
245 |
$3K |
| 73130 |
|
315 |
304 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,810 |
2,405 |
$3K |
| 82043 |
|
703 |
699 |
$3K |
| 90716 |
|
170 |
170 |
$3K |
| 87186 |
|
845 |
808 |
$3K |
| 93017 |
|
38 |
38 |
$3K |
| 86140 |
|
1,868 |
1,697 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
242 |
231 |
$3K |
| 90734 |
|
144 |
144 |
$3K |
| 90688 |
|
93 |
93 |
$3K |
| 92567 |
|
136 |
136 |
$2K |
| 73564 |
|
191 |
191 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
14 |
14 |
$2K |
| 84153 |
|
113 |
112 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
148 |
148 |
$2K |
| 80076 |
|
225 |
220 |
$2K |
| 90698 |
|
105 |
105 |
$2K |
| 0031A |
|
48 |
48 |
$2K |
| 94010 |
|
159 |
129 |
$2K |
| 72100 |
|
79 |
79 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
13 |
13 |
$2K |
| 83550 |
|
384 |
369 |
$2K |
| 0013A |
|
41 |
41 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
41 |
40 |
$2K |
| 83690 |
|
2,245 |
2,095 |
$2K |
| 86618 |
|
139 |
139 |
$1K |
| 0002A |
|
37 |
36 |
$1K |
| 71250 |
|
12 |
12 |
$1K |
| 71271 |
|
37 |
37 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
38 |
38 |
$1K |
| 86762 |
|
95 |
95 |
$1K |
| 84484 |
|
2,797 |
1,662 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
54 |
54 |
$1K |
| 80306 |
|
237 |
230 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
45 |
45 |
$1K |
| 85730 |
|
739 |
718 |
$1K |
| 74018 |
|
139 |
132 |
$1K |
| 0001A |
|
48 |
48 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
14 |
14 |
$994.35 |
| 90685 |
|
54 |
54 |
$974.74 |
| 80305 |
|
651 |
607 |
$968.08 |
| 85007 |
|
417 |
348 |
$940.47 |
| 90700 |
|
51 |
51 |
$922.88 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
114 |
114 |
$896.85 |
| 85652 |
|
516 |
484 |
$896.53 |
| 87420 |
|
348 |
339 |
$805.79 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
69 |
63 |
$803.56 |
| 96127 |
|
215 |
206 |
$766.91 |
| 87400 |
|
556 |
540 |
$763.68 |
| 90651 |
|
31 |
31 |
$742.01 |
| 87430 |
|
616 |
611 |
$731.99 |
| 87158 |
|
1,218 |
1,176 |
$721.65 |
| 94727 |
|
27 |
27 |
$682.53 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
15 |
15 |
$643.69 |
| 82150 |
|
571 |
539 |
$642.03 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
190 |
159 |
$633.84 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,132 |
1,131 |
$615.96 |
| 76536 |
|
25 |
25 |
$598.34 |
| 93971 |
|
28 |
27 |
$568.22 |
| 72110 |
|
32 |
32 |
$554.04 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
13 |
12 |
$548.94 |
| 87070 |
|
164 |
153 |
$523.39 |
| 90744 |
|
26 |
26 |
$471.26 |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
17 |
12 |
$458.29 |
| 90656 |
|
18 |
18 |
$451.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
905 |
833 |
$425.74 |
| 84703 |
|
841 |
804 |
$357.68 |
| 84436 |
|
96 |
96 |
$353.40 |
| 84100 |
|
214 |
179 |
$351.48 |
| 86706 |
|
39 |
39 |
$299.52 |
| 85018 |
|
230 |
226 |
$290.41 |
| 94729 |
|
12 |
12 |
$280.60 |
| 90710 |
|
12 |
12 |
$279.98 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
12 |
12 |
$276.70 |
| 86038 |
|
53 |
53 |
$272.24 |
| 82950 |
|
77 |
77 |
$269.59 |
| 90713 |
|
13 |
13 |
$232.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,006 |
2,743 |
$227.80 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,080 |
1,011 |
$196.21 |
| 83615 |
|
56 |
51 |
$192.71 |
| 86704 |
|
24 |
24 |
$175.66 |
| 73502 |
|
25 |
25 |
$165.26 |
| 87040 |
|
565 |
318 |
$149.98 |
| 83605 |
|
806 |
720 |
$91.10 |
| 74019 |
|
28 |
28 |
$70.56 |
| 87205 |
|
56 |
52 |
$60.78 |
| 84480 |
|
12 |
12 |
$59.34 |
| 82247 |
|
31 |
30 |
$57.21 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,677 |
2,476 |
$40.91 |
| 84479 |
|
14 |
14 |
$37.95 |
| 84550 |
|
16 |
15 |
$35.21 |
| 90473 |
|
253 |
253 |
$34.28 |
| 84145 |
|
157 |
152 |
$33.40 |
| 82550 |
|
28 |
24 |
$31.50 |
| 82565 |
|
13 |
12 |
$30.18 |
| 82248 |
|
14 |
13 |
$20.08 |
| 82040 |
|
13 |
13 |
$19.96 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
633 |
537 |
$13.29 |
| 80320 |
|
55 |
52 |
$10.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,134 |
1,071 |
$5.81 |
| J2704 |
Injection, propofol, 10 mg |
828 |
808 |
$5.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
181 |
157 |
$5.46 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
43 |
42 |
$2.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
911 |
896 |
$2.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
43 |
38 |
$1.13 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
238 |
223 |
$0.62 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
83 |
82 |
$0.25 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
32 |
24 |
$0.00 |
| 99080 |
|
2,337 |
2,313 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
52 |
27 |
$0.00 |
| 90461 |
|
267 |
267 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
80 |
71 |
$0.00 |
| 80179 |
|
13 |
12 |
$0.00 |
| 80143 |
|
14 |
12 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
12 |
12 |
$0.00 |
| 96160 |
|
14 |
14 |
$0.00 |
| 3078F |
|
12 |
12 |
$0.00 |
| 96376 |
|
369 |
265 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
64 |
62 |
$0.00 |
| 3079F |
|
25 |
25 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
45 |
44 |
$0.00 |
| 3074F |
|
79 |
78 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$0.00 |